Zamicastat

CAS: 1080028-80-3

Ref. 3D-FTB02880

Produktinformation

• Name: Zamicastat
• Synonyme: 1-[(3R)-6,8-Difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-2H-imidazole-2-thione, 2H-Imidazole-2-thione, 1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-, (R)-5-(2-(Benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione

Beschreibung

Zamicastat is a drug that is used in the treatment of vascular dementia, including multi-infarct dementia and Alzheimer's disease. It has been shown to reduce systolic pressure and improve clinical response in patients with congestive heart failure. Zamicastat inhibits the production of dopamine β-hydroxylase, which is an enzyme that catalyzes the conversion of dopamine to norepinephrine. It also inhibits the production of chemoattractant protein, an inflammatory mediator. This drug is being investigated as a possible diagnostic agent for cardiac hypertrophy and sildenafil for the treatment of erectile dysfunction.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 401.5 g/mol
• Formel: C₂₁H₂₁F₂N₃OS
• Reinheit: Min. 95%